Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Bicycle Therapeutics (BCYC) Leases (2019 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Leases for 8 consecutive years, with $14.5 million as the latest value for Q1 2026.

  • For Q1 2026, Leases rose 116.55% year-over-year to $14.5 million; the TTM value through Mar 2026 reached $14.5 million, up 116.55%, while the annual FY2025 figure was $15.9 million, 107.04% up from the prior year.
  • Leases hit $14.5 million in Q1 2026 for Bicycle Therapeutics, down from $15.9 million in the prior quarter.
  • Across five years, Leases topped out at $18.7 million in Q1 2023 and bottomed at $4.6 million in Q3 2025.
  • Average Leases over 5 years is $12.3 million, with a median of $13.5 million recorded in 2022.
  • Year-over-year, Leases skyrocketed 350.15% in 2022 and then crashed 49.82% in 2025.
  • Bicycle Therapeutics' Leases stood at $13.7 million in 2022, then dropped by 3.58% to $13.2 million in 2023, then tumbled by 41.73% to $7.7 million in 2024, then surged by 107.04% to $15.9 million in 2025, then fell by 8.5% to $14.5 million in 2026.
  • According to Business Quant data, Leases over the past three periods came in at $14.5 million, $15.9 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.